Conference Proceedings

Enhancing antitumor immune responses with clinical BET bromodomain inhibitor RG6146

Simon J Hogg, Lisa Wellinger, Daniel Rohle, Ricky W Johnstone

Experimental and Molecular Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2019